Know every physician.
Reach every patient.
Know every physician.
Reach every patient.
Know every physician.
Reach every patient.
Know every physician.
Reach every patient.
Know every physician.
Reach every patient.
Know every physician.
Reach every patient.
Know every physician.
Reach every patient.
Spellbinder is the physician intelligence layer for clinical trials, medical affairs, and commercial teams. Finished work, not data to analyze or tools to operate.
Spellbinder is the physician intelligence layer for clinical trials, medical affairs, and commercial teams. Finished work, not data to analyze or tools to operate.
Smart Targeting
The right physicians, delivered to youThe right physicians, delivered to youThe right physicians, delivered to youThe right physicians, delivered to youThe right physicians, delivered to youWe deliver the ranked list, you don't build it. For clinical teams, physicians are ranked by patient population match. For medical affairs, by peer-network position and scientific influence. For commercial, by conversion potential. No SQL to write. No vendor data to reconcile. No "Early Adopter" taxonomy to maintain. The list is ready when your team arrives at work.
Targeting accuracy. Sales teams prioritize physicians by conversion potential and receptiveness to new treatments.
Targeting accuracy. Sales teams prioritize physicians by conversion potential and receptiveness to new treatments.
Targeting accuracy. Sales teams prioritize physicians by conversion potential and receptiveness to new treatments.
Targeting accuracy. Sales teams prioritize physicians by conversion potential and receptiveness to new treatments.
Targeting accuracy. Sales teams prioritize physicians by conversion potential and receptiveness to new treatments.
96%
Complete Context
Every name on your list comes with a complete dossier, prescribing trends, clinical trial history, publications, industry relationships, hospital affiliations, and peer networks.
The same dossier serves every team. A CRC screening referring investigators, an MSL preparing for scientific exchange, a rep heading into call prep, one source of truth, delivered fresh.
Every name on your list comes with a complete dossier, prescribing trends, clinical trial history, publications, industry relationships, hospital affiliations, and peer networks.
The same dossier serves every team. A CRC screening referring investigators, an MSL preparing for scientific exchange, a rep heading into call prep, one source of truth, delivered fresh.
Updated in real time from 400+ public datasets. Zero integration with your internal systems required.
Updated in real time from 400+ public datasets. Zero integration with your internal systems required.
Updated in real time from 400+ public datasets. Zero integration with your internal systems required.
1.2M+
| Year | CPT/HCPCS | Procedure Name | Volume | Patients | Medicare Allowed | Medicare Paid |
|---|---|---|---|---|---|---|
| 2023 | 99214 | Established patient office or other outpatient visit, 30-39 minutes | 149 | 141 | $12,248.28 | $9,798.62 |
| 2023 | 99204 | New patient office or other outpatient visit, 45-59 minutes | 104 | 104 | $10,279.14 | $8,223.31 |
| 2023 | 99213 | Established patient office or other outpatient visit, 20-29 minutes | 48 | 47 | $2,770.24 | $2,216.19 |
| 2023 | 93980 | Complete ultrasound of penis artery and vein blood flow | 32 | 32 | $1,595.61 | $1,276.49 |
| Year | Drug | Generic | Scripts | Patients | Days of Supply | Total Drug Cost |
|---|---|---|---|---|---|---|
| 2023 | Testosterone | Testosterone | 30 | 12 | 1,670 | $6,959.72 |
| 2023 | Testosterone Cypionate | Testosterone Cypionate | 31 | 19 | 1,329 | $1,115.94 |
| 2023 | Clomid | Clomiphene Citrate | 12 | 0 | 624 | $921.43 |
| Company | Total Amount | Top Products | Payment Type |
|---|---|---|---|
| Pfizer Inc. | $80,141.42 | VIAGRA, CAVERJECT | Consulting, Speaker, Travel |
| Auxilium Pharmaceuticals | $58,837.23 | XIAFLEX, STENDRA, TESTIM | Consulting, Speaker, Travel |
| Mylan Inc. | $20,719.10 | VIAGRA | Consulting, Travel |
| Endo Pharmaceuticals | $15,243.62 | XIAFLEX, AVEED, TESTOPEL | Consulting, Food and Beverage |
| Lilly USA, LLC | $15,474.97 | CIALIS | Consulting, Travel |
| AbbVie, Inc. | $12,990.02 | Androgel, Humira, Lupron | Consulting |
| Study | NCT ID | Phase | Role | Status | Sponsor |
|---|---|---|---|---|---|
| Enzalutamide + Leuprolide in Nonmetastatic Prostate Cancer (EMBARK) | NCT02319837 | Phase 3 | Investigator | Active | Astellas / Pfizer |
| Tadalafil After Radical Prostatectomy (REACTT) | NCT01026818 | Phase 4 | Publication Author | Completed | Eli Lilly and Company |
| Avanafil for ED Post-Prostatectomy | NCT00895011 | Phase 3 | Study Director | Completed | VIVUS LLC |
| Pharmacological Penile Rehabilitation After Bilateral Nerve-Sparing RP | NCT00955929 | NA | Principal Investigator | Terminated | Memorial Sloan Kettering |
| Prograf in the Prevention of ED After Radical Prostatectomy | NCT00106392 | Phase 4 | Publication Author | Completed | Astellas Pharma Inc |
Complete Context
Every name on your list comes with a complete dossier, prescribing trends, clinical trial history, publications, industry relationships, hospital affiliations, and peer networks.
The same dossier serves every team. A CRC screening referring investigators, an MSL preparing for scientific exchange, a rep heading into call prep, one source of truth, delivered fresh.
1.2M+
Physician profiles with prescribing data, clinical trials, publications, and professional networks. Updated in real-time.
1,231,982 physician records • Updated in real-time
See exactly which treatments they're prescribing, how often, and for how many patients. Track monthly trends and generic vs branded preferences that reveal their prescribing philosophy.
Understand their patient volume, subspecialties, hospital affiliations, and practice context. Know the environment they work in before your first conversation.
Access their complete clinical trial history and active studies. Their research focus shows you exactly what therapeutic problems matter most to them.
Know which companies already have their attention through speaking fees, consulting roles, and advisory boards. Identify competitive dynamics and white space opportunities.
Read their recent work to understand their clinical perspectives and treatment philosophies. Each paper reveals what evidence resonates with them.
1,231,982 physician records • Updated in real-time
See exactly which treatments they're prescribing, how often, and for how many patients. Track monthly trends and generic vs branded preferences that reveal their prescribing philosophy.
Understand their patient volume, subspecialties, hospital affiliations, and practice context. Know the environment they work in before your first conversation.
Access their complete clinical trial history and active studies. Their research focus shows you exactly what therapeutic problems matter most to them.
Know which companies already have their attention through speaking fees, consulting roles, and advisory boards. Identify competitive dynamics and white space opportunities.
Read their recent work to understand their clinical perspectives and treatment philosophies. Each paper reveals what evidence resonates with them.
1,231,982 physician records • Updated in real-time
See exactly which treatments they're prescribing, how often, and for how many patients. Track monthly trends and generic vs branded preferences that reveal their prescribing philosophy.
Understand their patient volume, subspecialties, hospital affiliations, and practice context. Know the environment they work in before your first conversation.
Access their complete clinical trial history and active studies. Their research focus shows you exactly what therapeutic problems matter most to them.
Know which companies already have their attention through speaking fees, consulting roles, and advisory boards. Identify competitive dynamics and white space opportunities.
Read their recent work to understand their clinical perspectives and treatment philosophies. Each paper reveals what evidence resonates with them.
1,231,982 physician records • Updated in real-time
1,231,982 physician records • Updated in real-time
See exactly which treatments they're prescribing, how often, and for how many patients. Track monthly trends and generic vs branded preferences that reveal their prescribing philosophy.
Understand their patient volume, subspecialties, hospital affiliations, and practice context. Know the environment they work in before your first conversation.
Access their complete clinical trial history and active studies. Their research focus shows you exactly what therapeutic problems matter most to them.
Know which companies already have their attention through speaking fees, consulting roles, and advisory boards. Identify competitive dynamics and white space opportunities.
Read their recent work to understand their clinical perspectives and treatment philosophies. Each paper reveals what evidence resonates with them.
Conversion Intelligence
Every interaction comes with a personalized brief. For CRCs, the eligibility questions match this physician's patient mix. For MSLs, the open scientific questions this KOL has been asking. For reps, the efficacy data this prescriber cares about, with objections anticipated.
The briefs refine themselves as you build the relationship. Every conversation gets smarter.
Every interaction comes with a personalized brief. For CRCs, the eligibility questions match this physician's patient mix. For MSLs, the open scientific questions this KOL has been asking. For reps, the efficacy data this prescriber cares about, with objections anticipated.
The briefs refine themselves as you build the relationship. Every conversation gets smarter.
Higher conversion rates by matching treatments to physician profiles and anticipating objections before they happen.
Higher conversion rates by matching treatments to physician profiles and anticipating objections before they happen.
Higher conversion rates by matching treatments to physician profiles and anticipating objections before they happen.
2.3x
Our Mission
Conversion Intelligence
We're building toward a world where no patient waits months for a treatment that could save their life. Where when a breakthrough happens anywhere in medicine, every relevant physician knows about it immediately.
A patient diagnosed with aggressive cancer won't lose precious weeks while their doctor learns about the treatment that could help them. Commercial success will happen faster, funding more R&D, creating more breakthroughs.
We're building toward a world where no patient waits months for a treatment that could save their life. Where when a breakthrough happens anywhere in medicine, every relevant physician knows about it immediately.
A patient diagnosed with aggressive cancer won't lose precious weeks while their doctor learns about the treatment that could help them. Commercial success will happen faster, funding more R&D, creating more breakthroughs.
"Spellbinder is driving more simplicity, clarity, and direction for our sales team. It minimized the amount of time they're doing research to figure out who they need to go talk to. They can just focus on getting in front of these physicians now."
Head of Commercial Operations
Emerging Pharmaceutical Company